Seasonal influenza nanoparticle vaccine (Novavax)

N/A

Report date: 2025/12/15 20:00:38

Base Information

Drug NameSeasonal influenza nanoparticle vaccine (Novavax)

Drug Alias NameNanoFlu

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovavax

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNovavax

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A